Is the Answer Blowing in the Windtree Therapeutics?
Windtree Therapeutics (WINT) has made more announcements in the last six months than many companies do in a decade. But for all the flash and forward-looking language—crypto treasuries, waste management acquisitions, real estate deals, and manufacturing partnerships—there’s one glaring omission: not a single one of these strategies appears to have actually closed, and none are related to… Read More »